Filing Details
- Accession Number:
- 0001483813-11-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-10 20:31:42
- Reporting Period:
- 2011-08-09
- Filing Date:
- 2011-08-10
- Accepted Time:
- 2011-08-10 20:31:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1159036 | Halozyme Therapeutics Inc | HALO | Biological Products, (No Disgnostic Substances) (2836) | 880488686 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1462354 | A Kurt Gustafson | 11388 Sorrento Valley Road San Diego CA 92121 | Vice President And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-08-09 | 8,000 | $5.88 | 8,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $5.7582 to $5.9600. The price reported in this column reflects the weighted average purchase price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
